相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension
Naga Chalasani et al.
GASTROENTEROLOGY (2020)
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Shiv K. Sarin et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The roles of galectins in hepatic diseases
Mei-Juan Sun et al.
JOURNAL OF MOLECULAR HISTOLOGY (2020)
Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma
Mengjia Song et al.
BRITISH JOURNAL OF CANCER (2020)
Galectins for Diagnosis and Prognostic Assessment of Human Diseases: An Overview of Meta-Analyses
Yiting Liu et al.
MEDICAL SCIENCE MONITOR (2020)
Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
Kostandinos Sideras et al.
SCIENTIFIC REPORTS (2019)
Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resection
Xiuming Zhang et al.
HEPATOLOGY INTERNATIONAL (2019)
Galectin-9 in autoimmune hepatitis Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis
Naoki Matsuoka et al.
MEDICINE (2019)
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Zoe Leung et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Role of Galectins in Tumors and in Clinical Immunotherapy
Feng-Cheng Chou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
Hee-Won Moon et al.
ANNALS OF LABORATORY MEDICINE (2018)
Abstracts of the 26th Annual Conference of APASL, February 15–19, 2017, Shanghai, China
Hepatology International (2017)
PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
Kostandinos Sideras et al.
ONCOIMMUNOLOGY (2017)
Hypermethylation of the galectin-3 promoter is associated with poor prognosis of acute-on-chronic hepatitis B liver failure
Jing Zhao et al.
DIGESTIVE AND LIVER DISEASE (2017)
Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients
Ruzica Lukic et al.
DISEASE MARKERS (2017)
Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016, Tokyo, Japan
Hepatology International (2016)
Galactin-3 and brain natriuretic peptide versus conventional echocardiography in the early detection of cirrhotic cardiomyopathy
Wael A. Abbas et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2016)
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
P-F Zhang et al.
CELL DEATH & DISEASE (2016)
MiRNA-22 inhibits oncogene galectin-1 in hepatocellular carcinoma
Yu You et al.
ONCOTARGET (2016)
Towards molecular mechanisms regulating the expression of galectins in cancer cells under microenvironmental stress conditions
Alexander V. Timoshenko
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Liver, pancreas, gastrointestinal diseases, microbiome
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2015)
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
Koji Fujita et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Galectin-1 Triggers Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Cells
Maria L. Bacigalupo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer
Chao-Chi Yeh et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Serum Galectin-3 Levels in Children with Chronic Hepatitis B Infection and Inactive Hepatitis B Carriers
Ali Güneş
MEDICAL SCIENCE MONITOR (2015)
Prognostic Significance of Serum Galectin-3 Levels in Patients with Hepatocellular Cancer and Chronic Viral Hepatitis
Mehmet Ulu et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2015)
UEG Week 2015 Poster Presentations
United European Gastroenterology Journal (2015)
Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma
Nada H. Eisa et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Galectin-4 serves as a prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinoma
Zhixiong Cai et al.
CANCER SCIENCE (2014)
SERUM GALECTIN-3 LEVELS IN PATIENTS WITH LIVER FAILURE AND ITS CORRELATION WITH PROGNOSIS
Y. -F. Yang et al.
JOURNAL OF HEPATOLOGY (2014)
Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
Shan-Shan Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells
Datong Zheng et al.
ONCOLOGY REPORTS (2014)
Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis
Yoshihiro Kamada et al.
PROTEOMICS CLINICAL APPLICATIONS (2013)
Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma
Maria L. Bacigalupo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Galectin-3 modulates phagocytosis-induced stellate cell activation and liver fibrosis in vivo
Joy X. Jiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Galectin-9 Acts as a Prognostic Factor with Antimetastatic Potential in Hepatocellular Carcinoma
Zhao-Yang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
How echinoccocosis affects potential cancer markers in plasma: galectin-3, sN-cadherin and sE-cadherin? A preliminary report
Joanna Giebultowicz et al.
DIAGNOSTIC PATHOLOGY (2012)
Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice
Vladislav Volarevic et al.
HEPATOLOGY (2012)
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
Hang Li et al.
HEPATOLOGY (2012)
Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection
Han Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver Disease
Kazuhiro Nomoto et al.
SCIENTIFIC WORLD JOURNAL (2012)
Serum galectin-3 levels in patients with nonalcoholic fatty liver disease
Yusuf Yilmaz et al.
CLINICAL BIOCHEMISTRY (2011)
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function
Josef Wanninger et al.
CYTOKINE (2011)
Elevation of Serum Galectin-3 and Liver Stiffness Measured by Transient Elastography in Biliary Atresia
S. Honsawek et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2011)
Galectin-3 ablation protects mice from diet-induced NASH: A major scavenging role for galectin-3 in liver
Carla Iacobini et al.
JOURNAL OF HEPATOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Galectin-1 and Its Involvement in Hepatocellular Carcinoma Aggressiveness
Daniela Spano et al.
MOLECULAR MEDICINE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Tumor-associated galectin-3 modulates the function of tumor-reactive T cells
Weiyi Peng et al.
CANCER RESEARCH (2008)
Expression of galectin-3 involved in prognosis of patients with hepatocellular carcinoma
Yasunori Matsuda et al.
HEPATOLOGY RESEARCH (2008)
Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
Keiko Nagahara et al.
JOURNAL OF IMMUNOLOGY (2008)
Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales
Julian P. T. Higgins et al.
STATISTICS IN MEDICINE (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice
K. Nomoto et al.
JOURNAL OF PATHOLOGY (2006)
Intracellular functions of galectins
FT Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
分享论文
